Griffin Hospital
1
17M
1
0.01
- Areas of investment
Summary
Griffin Hospital appeared to be the Corporate Investor, which was created in 1909. The main department of described Corporate Investor is located in the Orange. The company was established in North America in United States.
The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2017.
The usual cause for the fund is to invest in rounds with 7 partakers. Despite the Griffin Hospital, startups are often financed by White Owl Capital Partners, Safeguard Scientifics, Kapor Capital. The meaningful sponsors for the fund in investment in the same round are White Owl Capital Partners, The Children's Hospital of Philadelphia, Sutter Health. In the next rounds fund is usually obtained by Robert Parkinson, Marc Benioff, Intermountain Healthcare.
Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Medical Device, Medical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Velano Vascular.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Rounds per year
- 0.01
- Investments by industry
- Medical (1)
- Health Care (1)
- Medical Device (1)
- Investments by region
-
- United States (1)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Velano Vascular | 07 Mar 2017 | Health Care, Medical Device, Medical | Early Stage Venture | 17M | United States, California, San Francisco |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.